383 related articles for article (PubMed ID: 24433482)
1. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.
Liu M; Solomon W; Cespedes JC; Wilson NO; Ford B; Stiles JK
J Neuroinflammation; 2018 Apr; 15(1):104. PubMed ID: 29636063
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
[TBL] [Abstract][Full Text] [Related]
4. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
[TBL] [Abstract][Full Text] [Related]
5. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
6. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
7. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
8. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
10. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
[TBL] [Abstract][Full Text] [Related]
14. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
[TBL] [Abstract][Full Text] [Related]
15. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
17. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
[TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
Canavese M; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
